MGP
MRK icon

Metis Global Partners’s Merck MRK Stock Holding History

Metis Global Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2M Sell
102,719
-30,745
-23% -$3.6M 0.3% 54
2026
Q1 		$16.1M Sell
133,464
-4,207
-3% -$486K 0.39% 35
2025
Q4 		$14.5M Sell
137,671
-4,967
-3% -$466K 0.34% 44
2025
Q3 		$12M Sell
142,638
-8,983
-6% -$740K 0.28% 51
2025
Q2 		$12M Sell
151,621
-16,415
-10% -$1.3M 0.31% 47
2025
Q1 		$15.1M Buy
168,036
+15,964
+10% +$1.49M 0.42% 38
2024
Q4 		$15.1M Buy
152,072
+2,782
+2% +$287K 0.46% 32
2024
Q3 		$17M Buy
149,290
+4,298
+3% +$511K 0.53% 27
2024
Q2 		$18M Buy
144,992
+1,440
+1% +$185K 0.62% 25
2024
Q1 		$18.9M Sell
143,552
-2,022
-1% -$249K 0.69% 23
2023
Q4 		$15.9M Buy
145,574
+16,730
+13% +$1.74M 0.63% 24
2023
Q3 		$13.3M Buy
128,844
+17,239
+15% +$1.86M 0.64% 23
2023
Q2 		$12.9M Buy
111,605
+1,904
+2% +$216K 0.69% 22
2023
Q1 		$11.7M Buy
109,701
+24,307
+28% +$2.62M 0.75% 19
2022
Q4 		$9.47M Buy
85,394
+32,377
+61% +$3.31M 0.84% 18
2022
Q3 		$4.57M Buy
53,017
+3,291
+7% +$294K 0.74% 20
2022
Q2 		$4.53M Buy
49,726
+7,445
+18% +$660K 0.73% 22
2022
Q1 		$3.47M Buy
42,281
+17,881
+73% +$1.41M 0.42% 33
2021
Q4 		$1.87M Buy
+24,400
New +$1.94M 0.52% 40

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Metis Global Partners's MRK Position: Q2 2026 in Review

Metis Global Partners reduced its Merck (MRK) stake by 23% in Q2 2026, selling an estimated $3.6M and leaving 102,719 shares worth $13.2M. The position accounts for 0.3% of the portfolio, ranked #54.

Metis Global Partners first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $18.9M in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Metis Global Partners held 102,719 shares of Merck worth $13.2M as of Q2 2026.
  • Metis Global Partners sold 30,745 Merck shares in Q2 2026, an estimated $3.6M.
  • Merck made up 0.3% of Metis Global Partners's portfolio in Q2 2026, its #54 holding.
  • Metis Global Partners first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Merck position peaked at $18.9M in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.